A Full Service Intellectual Property Firm
Safeguarding innovation demands proactive IP counsel known for thought leadership and creative legal strategies. Safeguarding innovation demands Oblon.
Oblon’s International Guest Program Welcomes Back Professor Elizabeth Winston
Oblon is honored to welcome back Professor Elizabeth Winston from the Columbus School of Law at The Catholic University of America. Professor Winston is a frequent speaker on a variety of intellectual property topics at conferences around the country.
Oblon Celebrates 50 years of Excellence
On September 13, 2018, Oblon celebrated its golden anniversary by hosting a party for all attorneys and staff at the Ballroom of the Westin Hotel in Alexandria, Virginia.
Oblon is Gold Sponsor for LESI 2019 Annual Conference
Oblon is a Gold sponsor of the LESI 2019 Annual Conference that will take place on May 26-28, 2019 in Yokohama Japan.
WHAT DOES AND/OR MEAN? IT DEPENDS
In an interesting, but non-precedential, decision from the Court of Appeals for the Federal Circuit (Supernus Pharmaceuticals, Inc. v TWI Pharmaceuticals, Inc et al(Fed. Cir., September 6, 2018-http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/17-2513.Opinion.9-6-2018.pdf), the Court affirmed a decision from the U.S. District Court of New Jersey.
JTEKT v. GKN: Federal Circuit Finds Competitor Lacks Standing to Appeal PTAB’s Final Written Decision
After determining that its competitor GKN’s patent raised a potential risk of infringement for a product under development, JTEKT challenged the patentability of claims 1–7 of U.S. Patent No. 8,215,440 via inter partes review (IPR2016-00046).
Recent Pharmaceutical House and Senate Bills
Over the summer, representatives introduced bills and amendments of interest to the pharmaceutical industry. First, Senator Orrin Hatch, co-author of the Hatch-Waxman Act, filed an amendment in the Senate Judiciary Committee that would require a generic manufacturer wishing to challenge a brand-name drug patent to choose between Hatch-Waxman litigation and IPR, removing the option to use both.
Oblon at the NOVA Veteran & Military Family Hiring Expo
Oblon will be participating at the NOVA Veteran & Military Family Hiring Expo on Tuesday, August 28th, 2018, from 11:00am - 2:00pm.
AIPPI ITC Seminar – Japan
You are invited to the AIPPI Japan ITC Seminar to be held on Friday, September 14, 2018 at 13:30-17:00
French Association of IP Specialists (ASPI) – France 2018
Philippe Signore has been invited to present by the French Association of IP Specialists (ASPI) and by Groupe Rhone-Alpes pour la Protection de la Propriete Industrielle (GRAPI) as part of their 2018 lecture series in France.
Chambers & Partners USA: America’s Leading Lawyers for Business
Oblon is honored to receive a prestigious Band 1 ranking from Chambers & Partners USA. The publication identified the firm as one of Northern Virginia’s leading firms in the area of intellectual property law.
Oblon Named a "Best Law Firm" by U.S. News and World Report
Oblon was named one of the “Best Law Firms” in the United States in 2018 by U.S. News and World Report and Best Lawyers.
Oblon Honored in The Legal 500 United States 2018
Oblon has been honored by The Legal 500 as one of America's leading firms in the area of patent: Prosecution (including reexamination and Post-Grant Proceedings).